Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia
- PMID: 22806892
- DOI: 10.1182/blood-2012-02-411124
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia
Abstract
Cytotoxic lymphodepletion therapies augment antitumor immune responses. The generation and therapeutic efficacy of antitumor effector T cells (T(E)s) are enhanced during recovery from lymphopenia. Although the effects of lymphodepletion on naive T cells (T(N)s) and T(E)s have been studied extensively, the influence of lymphodepletion on suppressor cells remains poorly understood. In this study, we demonstrate a significant increase of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) in sublethally irradiated lymphopenic mice. These radio-resistant Tregs inhibited the induction of T(E)s in tumor-draining lymph-nodes (TDLNs) during recovery from lymphopenia. The transfer of T(N)s into lymphopenic tumor-bearing mice resulted in some antitumor effects; however, Treg depletion after whole-body irradiation and reconstitution strongly inhibited tumor progression. Further analyses revealed that tumor-specific T cells were primed from the transferred T(N)s, whereas the Tregs originated from irradiated recipient cells. As in irradiated lymphopenic mice, a high percentage of Tregs was observed in cyclophosphamide-treated lymphopenic mice. The inhibition of Tregs in cyclophosphamide-treated mice significantly reduced tumor growth. These results indicate that the Tregs that survive cytotoxic therapies suppress antitumor immunity during recovery from lymphopenia and suggest that approaches to deplete radio and chemo-resistant Tregs can enhance cancer immunotherapies.
Comment in
-
Stubborn Tregs limit T-cell therapy.Blood. 2012 Sep 20;120(12):2352-4. doi: 10.1182/blood-2012-08-445239. Blood. 2012. PMID: 22996654
Similar articles
-
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.J Immunol. 2015 Jul 15;195(2):726-35. doi: 10.4049/jimmunol.1401468. Epub 2015 Jun 3. J Immunol. 2015. PMID: 26041539
-
PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion.Front Immunol. 2020 Jan 28;11:52. doi: 10.3389/fimmu.2020.00052. eCollection 2020. Front Immunol. 2020. PMID: 32047502 Free PMC article.
-
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.Blood. 2011 Sep 15;118(11):3003-12. doi: 10.1182/blood-2011-02-334565. Epub 2011 Jul 18. Blood. 2011. PMID: 21768296 Free PMC article. Clinical Trial.
-
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective.Cancer Res. 2012 Jul 15;72(14):3439-44. doi: 10.1158/0008-5472.CAN-11-3912. Epub 2012 Jul 3. Cancer Res. 2012. PMID: 22761338 Free PMC article. Review.
-
Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.Immunol Res. 2014 Jan;58(1):101-5. doi: 10.1007/s12026-013-8476-x. Immunol Res. 2014. PMID: 24371009 Review.
Cited by
-
miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development.Front Immunol. 2018 Nov 5;9:2497. doi: 10.3389/fimmu.2018.02497. eCollection 2018. Front Immunol. 2018. PMID: 30455689 Free PMC article.
-
TGF-β1 mediates the radiation response of prostate cancer.J Mol Med (Berl). 2015 Jan;93(1):73-82. doi: 10.1007/s00109-014-1206-6. Epub 2014 Sep 18. J Mol Med (Berl). 2015. PMID: 25228112
-
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.Cancer Immunol Immunother. 2022 Jun;71(6):1357-1369. doi: 10.1007/s00262-021-03078-0. Epub 2021 Oct 17. Cancer Immunol Immunother. 2022. PMID: 34657194 Free PMC article.
-
Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.PLoS One. 2013 Sep 2;8(9):e73952. doi: 10.1371/journal.pone.0073952. eCollection 2013. PLoS One. 2013. Retraction in: PLoS One. 2023 Feb 2;18(2):e0281611. doi: 10.1371/journal.pone.0281611 PMID: 24023916 Free PMC article. Retracted.
-
Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner.Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2404916121. doi: 10.1073/pnas.2404916121. Epub 2024 Aug 29. Proc Natl Acad Sci U S A. 2024. PMID: 39207730
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials